Trial
NCT04411602
Intermediate IND Severe Illness COVID-19 CP
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Henry Ford Health System
Collaborators
—
Condition
Severe Acute Respiratory Syndrome
Intervention
SARS-CoV-2 plasma
Why stopped
No participants due to waning pandemic.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-19